LINKS

David A. Barbie, MD, Dana-Farber Cancer Institute
Adam Bass, MD,
Andrew H. Beck, MD, PhD, PathAI
Monica M. Bertagnolli, MD, Director of National Cancer Institute, National Institutes of Health
Carlos A. Camargo, Jr. MD, DrPH, Massachusetts General Hospital
Fernando Camargo, PhD, Harvard Stem Cell Institute, Children’s Hospital Boston
Peter T. Campbell, PhD, Albert Einstein College of Medicine
Lewis C. Cantley, PhD, Dana-Farber Cancer Institute
Andrew T. Chan, MD, MPH, Massachusetts General Hospital
Jennifer A. Chan, MD, Dana-Farber Cancer Institute
Eunyoung Cho, ScD, Brown University
David C. Christiani, MD, MPH, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital
Daniel C. Chung, MD, Massachusetts General Hospital
George Q. Daley, MD, PhD, Dean of Harvard Medical School
Dora Dias-Santagata, PhD, Massachusetts General Hospital
Glenn Dranoff, MD, Novartis
Jeffrey A. Engelman, MD, PhD, Massachusetts General Hospital
Alison E. Field, ScD, Brown University
Ron Firestein, MD, PhD, Genentech
David A. Frank, MD, PhD, Dana-Farber Cancer Institute
Charles S. Fuchs, MD, MPH, Genentech / Roche
Jerome Galon, PhD, INSERM
Levi A. Garraway, MD, Eli Lilly
Wendy S. Garrett, MD, PhD, Harvard T.H. Chan School of Public Health
Marios Giannakis, MD, PhD, Dana-Farber Cancer Institute, The Broad Institute
Edward Giovannucci, MD, MPH, ScD, Harvard T.H. Chan School of Public Health
Ajay Goel, PhD, City of Hope National Medical Center
Wolfram Goessling, MD, PhD, Harvard Stem Cell Institute
Todd R. Golub, MD, The Broad Institute of MIT and Harvard
Michael Green, MD, PhD, University of Massachusetts
Wayne W. Grody, MD, PhD, UCLA
Kevin M. Haigis, PhD, Dana-Farber Cancer Institute
Curtis C. Harris, MD, National Cancer Institute, National Institute of Health
Richard O. Haynes, PhD, Koch Institute for Integrative Cancer Research, MIT
Jason L. Hornick, MD, PhD, Brigham and Women’s Hospital
Yujin Hoshida, MD, UT Southwestern Medical Center
Frank B. Hu, MD, PhD, Harvard T.H. Chan School of Public Health
David J. Hunter, MBBS, ScD, Oxford University
Curtis Huttenhower, PhD, Harvard T.H. Chan School of Public Health
Anthony John Iafrate, MD, PhD, Massachusetts General Hospital
Rudolf Jaenisch, MD, Whitehead Institute, MIT
Ichiro Kawachi, MD, PhD, Harvard T.H. Chan School of Public Health
Hamed Khalili, MD, Massachusetts General Hospital
Peter Kraft, PhD, Harvard T.H. Chan School of Public Health
Matthew H. Kulke, MD, MMSc, Boston University
Raju Kucherlapati, PhD, Harvard Medical School
Peter W. Laird, PhD,
Jung Eun Lee, ScD, Sookmyung Women’s University
Barbara Leggett, MD, Queensland Institute of Medical Research
Debra Leonard, MD, PhD, University of Vermont
Neal I. Lindeman, MD, Brigham and Women’s Hospital
Paul Lochhead, MBChB, MRCP, Massachusetts General Hospital
Massimo Loda, MD, Weill Cornell Medicine
Janina A. Longtine, MD,
Umar Mahmood, MD, PhD, Massachusetts General Hospital
G. Mike Makrigiorgos, PhD, Dana-Farber Cancer Institute
Sanford D. Markowitz, MD, PhD, Case Western Reserve University
Alexander Meisser, PhD, The Broad Institute, Harvard University
Jeffrey A. Meyerhardt, MD, MPH, Dana-Farber Cancer Institute
Matthew Meyerson, MD, PhD, Dana-Farber Cancer Institute, The Broad Institute
Danny A. Milner, MD, MS,
Mari Mino-Kenudson, MD, Massachusetts General Hospital
George F. Murphy, MD, Brigham and Women’s Hospital
Hongmei Nan, MD, PhD, Indiana Univerisity
Polly A. Newcomb, PhD, MPH, Fred Hutchinson Cancer Center
Kimmie Ng, MD, MPH, Dana-Farber Cancer Institute
Jukka-Pekka Onnela, DSc, Harvard T.H. Chan School of Public Health
Giovanni Parmigiani, PhD, Dana-Farber Cancer Institute
Ulrike Peters, PhD, Fred Hutchinson Cancer Center
Amanda I. Phipps, PhD, University of Washington
Michael N. Pollak, MD, McGill University
John Quackenbush, PhD, Harvard T.H. Chan School of Public Health

Timothy Rebbeck, PhD, Dana-Farber Cancer Institute
Bernard A. Rosner, PhD, Harvard T.H. Chan School of Public Health
Eva S. Schernhammer, MD, DrPH, Brigham and Women’s Hospital
Deborah Schrag, MD, MPH, Memorial Sloan Kettering Cancer Center
Mark E. Sherman, MD, Mayo Clinic
Ramesh A. Shivdasani, MD, PhD, Dana-Farber Cancer Institute
David A. Sinclair, PhD, Harvard Medical School
Stephanie A. Smith-Warner, PhD, Harvard T.H. Chan School of Public Health
Donna Spiegelman, ScD, Yale University
Meir J. Stampfer, MD, DrPH, Brigham and Women’s Hospital
Andy S. Tan, PhD, MPH, MBA, MBBS
Sarah P Thayer, MD, PhD, Massachusetts General Hospital
Matthew Vander Heiden, MD, PhD, Koch Institute for Integrative Cancer Research, MIT
Tyler J. VanderWeele, PhD, Harvard T.H. Chan School of Public Health
Molin Wang, PhD, Harvard T.H. Chan School of Public Health

Elisabete Weiderpass, MD, International Agency for Research on Cancer (IARC)
Vicki Whitehall, PhD, Queensland Institute of Medical Research
Walter C. Willett, MD, DrPH, Harvard T.H. Chan School of Public Health
Michelle A. Williams, ScD, Harvard T.H. Chan School of Public Health
Robert B. Wilson, MD, PhD, University of Pennsylvania
Brian M. Wolpin, MD, MPH, Dana-Farber Cancer Institute